97 related articles for article (PubMed ID: 12615712)
1. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
[TBL] [Abstract][Full Text] [Related]
2. Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin.
Kiani Ghalesardi O; Zaker F; Ghotaslou A; Boustani H; Rezvani MR; Kiani J; Shahidi M
Gene; 2023 Sep; 880():147622. PubMed ID: 37419428
[TBL] [Abstract][Full Text] [Related]
3. dNTP Supply Gene Expression Patterns after P53 Loss.
Radivoyevitch T; Saunthararajah Y; Pink J; Ferris G; Lent I; Jackson M; Junk D; Kunos CA
Cancers (Basel); 2012 Nov; 4(4):1212-24. PubMed ID: 23205301
[TBL] [Abstract][Full Text] [Related]
4. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductase.
Shao J; Zhou B; Zhu L; Qiu W; Yuan YC; Xi B; Yen Y
Cancer Res; 2004 Jan; 64(1):1-6. PubMed ID: 14729598
[TBL] [Abstract][Full Text] [Related]
6. p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.
Zhang K; Wu J; Wu X; Wang X; Wang Y; Zhou N; Kuo ML; Liu X; Zhou B; Chang L; Ann D; Yen Y
Mol Cancer Ther; 2011 Feb; 10(2):269-78. PubMed ID: 21216934
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inactivation of human ribonucleotide reductase with p53R2 by gemcitabine 5'-diphosphate.
Wang J; Lohman GJ; Stubbe J
Biochemistry; 2009 Dec; 48(49):11612-21. PubMed ID: 19899807
[TBL] [Abstract][Full Text] [Related]
8. New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine.
Veltkamp SA; Pluim D; van Eijndhoven MA; Bolijn MJ; Ong FH; Govindarajan R; Unadkat JD; Beijnen JH; Schellens JH
Mol Cancer Ther; 2008 Aug; 7(8):2415-25. PubMed ID: 18723487
[TBL] [Abstract][Full Text] [Related]
9. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant.
Bergman AM; Eijk PP; Ruiz van Haperen VW; Smid K; Veerman G; Hubeek I; van den Ijssel P; Ylstra B; Peters GJ
Cancer Res; 2005 Oct; 65(20):9510-6. PubMed ID: 16230416
[TBL] [Abstract][Full Text] [Related]
10. Activator protein accelerates dihydropyrimidine dehydrogenase gene transcription in cancer cells.
Ukon K; Tanimoto K; Shimokuni T; Noguchi T; Hiyama K; Tsujimoto H; Fukushima M; Toge T; Nishiyama M
Cancer Res; 2005 Feb; 65(3):1055-62. PubMed ID: 15705907
[TBL] [Abstract][Full Text] [Related]
11. The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity.
Prasad CB; Oo A; Liu Y; Qiu Z; Zhong Y; Li N; Singh D; Xin X; Cho YJ; Li Z; Zhang X; Yan C; Zheng Q; Wang QE; Guo D; Kim B; Zhang J
Nat Commun; 2024 May; 15(1):4667. PubMed ID: 38821952
[TBL] [Abstract][Full Text] [Related]
12. The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity.
Prasad CB; Oo A; Qiu Z; Li N; Singh D; Xin X; Cho YJ; Li Z; Zhang X; Yan C; Zheng Q; Shao J; Wang QE; Kim B; Zhang J
Res Sq; 2023 May; ():. PubMed ID: 37205570
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer.
Yin X; Jiang K; Zhou Z; Yu H; Yan D; He X; Yan S
Oxid Med Cell Longev; 2023; 2023():3878796. PubMed ID: 36713030
[TBL] [Abstract][Full Text] [Related]
14. Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation.
Kang YJ; Yang WG; Chae WS; Kim DW; Kim SG; Rotaru H
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856441
[TBL] [Abstract][Full Text] [Related]
15. Requirement and functional redundancy of two large ribonucleotide reductase subunit genes for cell cycle, chloroplast biogenesis and photosynthesis in tomato.
Gu M; Lu Q; Liu Y; Cui M; Si Y; Wu H; Chai T; Ling HQ
Ann Bot; 2022 Sep; 130(2):173-187. PubMed ID: 35700127
[TBL] [Abstract][Full Text] [Related]
16. Purine nucleoside phosphorylase deficiency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons.
Tsui M; Biro J; Chan J; Min W; Dobbs K; Notarangelo LD; Grunebaum E
Sci Rep; 2022 May; 12(1):9084. PubMed ID: 35641516
[TBL] [Abstract][Full Text] [Related]
17. Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes.
Zavileyskiy L; Bunik V
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204825
[TBL] [Abstract][Full Text] [Related]
18. A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients.
Chen S; Duan Y; Wu Y; Yang D; An J
Front Pharmacol; 2021; 12():728368. PubMed ID: 34393804
[No Abstract] [Full Text] [Related]
19. Integrative Analysis Reveals Across-Cancer Expression Patterns and Clinical Relevance of Ribonucleotide Reductase in Human Cancers.
Ding Y; Zhong T; Wang M; Xiang X; Ren G; Jia Z; Lin Q; Liu Q; Dong J; Li L; Li X; Jiang H; Zhu L; Li H; Shen D; Teng L; Li C; Shao J
Front Oncol; 2019; 9():956. PubMed ID: 31637211
[TBL] [Abstract][Full Text] [Related]
20. Rrm2b deletion causes mitochondrial metabolic defects in renal tubules.
Chen YF; Lin IH; Guo YR; Chiu WJ; Wu MS; Jia W; Yen Y
Sci Rep; 2019 Sep; 9(1):13238. PubMed ID: 31519977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
